Search
SOLACI Congress
HomeValvular Aortic valveVálvula Aórtica

Válvula Aórtica

View Category
Structural heart disease

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe...
Dr. Carlos Fava -
Learn More
Antithrombotic Anticoagulants

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series....
Dr. Carlos Fava -
Learn More
Structural heart disease

Impact of Iliofemoral Disease on Post TAVR Clinical Outcomes: HOSTILE Score Validation

At present, transcatheter aortic valve replacement (TAVR) has been shown safe and effective for treating severe symptomatic...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

Asymmetry in the Implantation of Self-Expanding Valves in TAVR: Evolution at 5 Years

Severe aortic stenosis is frequently associated with significant and irregular calcification, which tends to be more present...
Dr. Carlos Fava -
Learn More
Structural heart disease

Aortic Stenosis with High Gradients and Area >1: Just Follow Up?

Definig severe aortic stenosis (AS) rests upon Doppler parameters, and uses log-established cutoff values, which include peak...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Comparison Between Leadless Pacemaker vs. Transvenous Pacemaker After Percutaneous Aortic Valve Replacement

Transcatheter aortic valve replacement (TAVR) has proven to be effective in treating severe aortic stenosis. The volume...
Dr. Andrés Rodríguez -
Learn More
Structural heart disease

ENVISAGE-TAVI AF Trial: What Anticoagulant Should We Use?

Between 15% and 30% of patients undergoing TAVR present atrial fibrillation. Many of them have suffered ischemic...
Dr. Carlos Fava -
Learn More
Antithrombotic Anticoagulants

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral...
Dr. Carlos Fava -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

Dr. Andrés Rodríguez - 0
In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

Dr. Andrés Rodríguez - 0
The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

TCT 2024 | Distal Radial vs Transradial Approach in STEMI Patients

Dr. Andrés Rodríguez - 0
The transradial approach (TRA) has been recommended for patients with ST-elevation myocardial infarction (STEMI) for reduced bleeding complications and mortality. However, evidence in support...

Institutional News

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Arequipa Sessions 2024: Meet the International Guests

solaci - 0
The Arequipa Sessions 2024 is getting closer and closer. Meet the international guests who will share their knowledge for 2 days at a high-level...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy